Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DiagnostykaFRA:7JS +0.26%26 3-Year Book Growth Rate is 19.10% as of Mar. 2026, which is 117% above its 10-year median of 8.80. GuruFocus rates FRA:7JS with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 192 Medical Diagnostics & Research companies, Diagnostyka ranks better than 86.98% on this metric.
During the past 12 months, Diagnostyka's average Book Value per Share Growth Rate was 22.80% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 19.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 5 years, the highest 3-Year average Book Value per Share Growth Rate of Diagnostyka was 19.10% per year. The lowest was -1.50% per year. And the median was 8.80% per year.
Diagnostyka (FRA:7JS) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Diagnostyka 3-Year Book Growth Rate Related Terms
FRA:7JS vs TMO, DHR, IDXX: 3-Year Book Growth Rate Comparison
For the Diagnostics & Research subindustry, Diagnostyka's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostyka 3-Year Book Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnostyka's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Diagnostyka's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 19.10% mean?
Diagnostyka (FRA:7JS) has a 3-Year Book Growth Rate of 19.10% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Diagnostyka and its competitors. This is 117% above median its historical median of 8.80. According to the industry distribution chart, Diagnostyka ranks #25 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 13%.
Is Diagnostyka's 3-Year Book Growth Rate too high?
Diagnostyka's current 3-Year Book Growth Rate of 19.10% is 117% above median its 10-year median of 8.80. Based on the distribution chart, Diagnostyka ranks #25 out of 192 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnostyka has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's 3-Year Book Growth Rate compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnostyka ranks #25 out of 192 companies for 3-Year Book Growth Rate. This places Diagnostyka in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Diagnostics & Research company?
A good 3-Year Book Growth Rate depends on the Medical Diagnostics & Research industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Diagnostyka and its competitors. Diagnostyka's current 3-Year Book Growth Rate is 19.10%, which is 117% above median its own 10-year median of 8.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current 3-Year Book Growth Rate of 19.10%. The current 3-Year Book Growth Rate is 19.10%, which is 117% above median its 10-year median of 8.80. Diagnostyka's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current 3-Year Book Growth Rate is 19.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
26GF Score
Get the complete analysis for FRA:7JS
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JS has been successfully added to your 
